Canadian medical technology research and development partnering delegation to Taiwan

Global Affairs Canada (GAC), through the Canadian Trade Office in Taipei, and in collaboration with the National Research Council of Canada’s Industrial Research Assistance Program (NRC IRAP), invites Canadian innovators to apply to participate in the Canadian Medical Technology Research and Development Partnering Delegation to Taiwan, under the Canadian International Innovation Program (CIIP).

The Partnership Development Activity (PDA), a Canadian International Innovation Program (CIIP) initiative, will occur in-person from December 2 to 5, 2025 in Taiwan.

Please note that interested companies must apply no later than September 9, 2025.

Anchored to Healthcare+ Expo Taiwan 2025, the delegation objective is to explore partnerships between Canadian small to medium-sized enterprises (SMEs), and potential Taiwanese partners for R&D collaboration and market expansion. Potential partners include: 

• SMEs
• multinational enterprises (MNEs)
• research institutions and academia

The delegation will focus on technologies and solutions including, but not limited to:

• artificial intelligence (AI) in healthcare
• robotics 
• diagnostic imaging
• AgeTech
• precision health
• healthcare IT 
• medical devices
• healthcare and wellness wearables
• telehealth
• healthcare cybersecurity 

Interested Canadian SMEs must be capable and ready to pursue joint R&D collaborations, with the goal of future commercialization, such as: 

• validation of Canadian technologies in the Taiwanese market
• adaptation of Canadian technologies to meet market characteristics
• co-development of new products and/or services combining Canadian and Taiwanese technologies

The delegation will consist of no more than 10 Canadian SMEs with demonstrated capabilities in innovative medical and digital health technologies.

Canadian companies wishing to participate in this delegation to Taiwan should meet the following requirements:

• Profit-oriented, small or medium-sized enterprise (less than 500 full-time employees) incorporated in Canada
• Previous experience in commercializing technology for domestic or international markets
• Capacity and interest in co-developing technology with Taiwanese partners
• Committed to expanding activities to the Taiwanese market
• Sufficient working capital and human resources to undertake multi-year R&D collaboration and commercialize the results

Dates: December 2 to 5, 2025

Location: Taipei and Taoyuan, in Taiwan

Program highlights will include:

Tuesday, December 2

• Briefing session and market overview
• Pre-arranged tailored B2B meetings with Taiwanese companies 

Wednesday, December 3

• Site visits to multinational enterprises in ICT manufacturing

Thursday, December 4

• Walkthrough of Healthcare+ Expo Taiwan 2025 Show
• Show guided tour and pre-arranged meetings with exhibitors including Taiwanese companies, hospitals, research institutions and academia

Friday, December 5

• Pitch session at the Canadian MedTech R&D Partnership Forum
• Pre-arranged tailored B2B meetings with Taiwanese companies, research institutions, and academia 

Strategic gateway for MedTech co-development

Taiwan is globally recognized for healthcare excellence, ranking #1 in the world for 7 consecutive years (number 2024). Taiwan offers a trusted, innovation-friendly environment backed by world-class research infrastructure, advanced manufacturing, and strong intellectual property (IP) protections. With 20% of its population projected to be 65+ by 2025, there is urgent demand for smart, patient-centered healthcare solutions. This is further supported by over CAD 5 billion in public investment starting in 2025 for AI diagnostics, smart hospitals, and telehealth. 

ICT manufacturing synergies

As a global leader in semiconductors, ICT, and precision manufacturing, Taiwan enables the seamless integration of AI, IoT, and big data into medical technologies. Major ICT MNEs are actively expanding into medical technology and connected healthcare. This reinforces Taiwan’s position as a strategic hub for co-developing, piloting, and scaling next-generation smart health solutions.

Thriving MedTech and R&D ecosystem

Taiwan’s MedTech sector is expected to reach CA$4.3 billion by 2025, with strengths in digital health, AI diagnostics, and precision medicine. The ecosystem includes 1,220+ MedTech firms, 157 academic institutions, 9 research organizations, and a world-class health data infrastructure—ideal for R&D partnerships and clinical validation.

Healthcare+ Expo Taiwan

Healthcare+ Expo Taiwan (December 4 to 7, 2025) is Asia’s premier hospital-led MedTech event. In 2024, the Expo attracted 215,000+ visitors, 650 exhibitors, 158 hospitals, and 2,500 global buyers. The 2025 edition will spotlight breakthroughs across MedTech, BioTech, and HealthTech, further positioning Taiwan as a gateway for international healthcare collaboration.

The Canadian International Innovation Program (CIIP) may provide financial support to eligible Canadian SMEs participants for up to 50% of all eligible expenses that include but are not limited to:

• economy class airfare
• local transportation
• accommodation
• meals (per diems)   
• conference registration fees

Consult CIIP Applicant Guide for the complete list of eligible expenses. To access the CIIP Applicant Guide, contact the CIIP team at innovation@international.gc.ca  

1. Click the “Apply” button to access the online application form. Select the official language of your choice, choose the delegation to which you want to apply, and then complete all questions.
2. Completed applications must be submitted online no later than September 9, 2025.
3. Global Affairs Canada, the Canadian Trade Office in Taipei, and NRC IRAP will select the Canadian companies that will participate in the delegation. Selected applicants will be notified no later than September 29, 2025.
4. Companies formally selected to participate in the delegation will be invited to apply for travel funding support. 

Global Affairs Canada in collaboration with the National Research Council Industrial Research Assistance Program (NRC-IRAP) delivers the Canadian International Innovation program (CIIP) in Taiwan. CIIP supports industrial R&D partnership development activities between Canadian SMEs and companies in key markets, including Taiwan.